Court Upholds Abbott's Claim Against Menschlich Healthcare, Protecting Public Interest and Trademark Integrity
In a significant ruling, the Bombay High Court has directed the rectification and removal of the trademark "DUPHACHRIT" from the Register of Trade Marks, citing deceptive similarity to Abbott Product Operations AG's well-established "DUPHA family of marks." The judgment, delivered by Justice Arif S. Doctor, underscores the stringent standards applied to pharmaceutical trademarks due to the potential risks of consumer confusion.
Abbott, represented by Mr. Hiren Kamod, contended that Menschlich Healthcare's "DUPHACHRIT" was phonetically, aurally, structurally, and visually similar to its trademarks, including "DUPHASTON" and "DUPHALAC." The court recognized Abbott's extensive use and established goodwill in the pharmaceutical sector, emphasizing the necessity for heightened scrutiny in cases involving medicinal products.
Respondent Menschlich Healthcare, represented by Mr. Chander M. Negi, argued that Abbott lacked exclusive rights to the "DUPHA" prefix. However, the court noted the prefix's association with Abbott's trademarks and concluded that Menschlich's adoption of "DUPHACHRIT" was both dishonest and intended to capitalize on Abbott's reputation.
The court's decision highlighted the paramount importance of public interest and maintaining the purity of the trademark register. It dismissed Menschlich's arguments about third-party usage and alleged fragmentation of rights, emphasizing that the burden of proving commonality lies with the respondent. Justice Doctor's ruling reiterated that even a slight possibility of confusion in pharmaceutical trademarks could have dire consequences for public health.
Abbott's legal victory reinforces the protection of its intellectual property, ensuring that consumers are not misled by deceptively similar trademarks in the pharmaceutical industry. The court's judgment serves as a reminder of the judiciary's role in safeguarding public interest and upholding the integrity of trademark registrations.
Bottom line:-
Trademark rectification - The entry of a deceptively similar trademark "DUPHACHRIT" in Class 5 on the Register of Trade Marks was ordered to be rectified, canceled, and removed, as it was found to be phonetically, aurally, structurally, and visually similar to the Petitioner's "DUPHA family of marks."
Statutory provision(s): Trade Marks Act, 1999 Sections 11(1), 11(2), 11(3), 11(10)(ii), 17, 57
